Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Selection bias and covariate imbalances in randomzied clinical trials [[electronic resource] /] / Vance W. Berger
| Selection bias and covariate imbalances in randomzied clinical trials [[electronic resource] /] / Vance W. Berger |
| Autore | Berger Vance |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley & Sons, c2005 |
| Descrizione fisica | 1 online resource (220 p.) |
| Disciplina |
610.724
610/.72/4 |
| Collana | Statistics in practice |
| Soggetto topico |
Clinical trials - Statistical methods - Evaluation
Ranking and selection (Statistics) - Evaluation Sampling (Statistics) - Evaluation |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-55597-1
9786610555970 0-470-86364-1 0-470-86363-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Selection Bias and Covariate Imbalances in Randomized Clinical Trials; Contents; Preface; Part I: Is There a Problem with Reliability in Medical Studies?; 1 An Evolution of Comparative Methodology; 1.1 Single-subject studies; 1.2 Case series and cohort studies; 1.3 Historical controls; 1.4 Parallel control groups; 1.5 Matched studies; 1.6 Randomization; 1.7 Advance randomization; 1.8 Allocation concealment; 1.9 Residual selection bias; 2 Susceptibility of Randomized Trials to Subversion and Selection Bias; 2.1 Can randomized trials be subverted?
2.2 If randomized trials are subverted, do they cease to be randomized trials?2.3 What is masking?; 2.4 What is allocation concealment?; 2.5 A double standard; 2.6 What if allocation concealment could be ensured?; 3 Evidence of Selection Bias in Randomized Trials; 3.1 The burden of proof regarding the existence of selection bias in randomized trials; 3.2 Indirect population-level evidence that selection bias exists in randomized trials; 3.3 Direct trial-level evidence that selection bias exists in randomized trials; 3.3.1 Heparin for myocardial infarction 3.3.2 University Group Diabetes Program3.3.3 Talc and mustine for pleural effusions; 3.3.4 Tonsillectomy for recurrent throat infection in children; 3.3.5 Oxytocin and amniotomy for induction of labor; 3.3.6 Western Washington Intracoronary Streptokinase Trial; 3.3.7 RSV immune globulin in infants and young children with respiratory syncytial virus; 3.3.8 A trial to assess episiotomy; 3.3.9 Canadian National Breast Cancer Screening Study; 3.3.10 Surgical trial; 3.3.11 Lifestyle Heart Trial; 3.3.12 Coronary Artery Surgery Study; 3.3.13 Etanercept for children with juvenile rheumatoid arthritis 3.3.14 Edinburgh Randomized Trial of Breast-Cancer Screening3.3.15 Captopril Prevention Project; 3.3.16 Göteborg (Swedish) Mammography Trial; 3.3.17 HIP Mammography Trial; 3.3.18 Hypertension Detection and Follow-Up Program; 3.3.19 Randomized trial to prevent vertical transmission of HIV-1; 3.3.20 Effectiveness trial of a diagnostic test; 3.3.21 South African trial of high-dose chemotherapy for metastatic breast cancer; 3.3.22 Randomized study of a culturally sensitive AIDS education program; 3.3.23 Runaway Youth Study; 3.3.24 Cluster randomized trial of palliative care 3.3.25 Randomized trial of methadone with or without heroin3.3.26 Randomized NINDS trial of tissue plasminogen activator for acute ischemic stroke; 3.3.27 Norwegian Timolol Trial; 3.3.28 Laparoscopic versus open appendectomy; 3.3.29 The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study; 3.3.30 The Heart Outcomes Prevention Evaluation (HOPE) Study; 3.4 In search of better evidence; 4 Impact of Selection Bias in Randomized Trials; 4.1 Quantifying the prediction of future allocations: balanced blocks; 4.2 Quantifying prediction of future allocations: unbalanced blocks 4.3 Quantifying covariate imbalance resulting from selection bias |
| Record Nr. | UNINA-9910144745303321 |
Berger Vance
|
||
| Hoboken, NJ, : John Wiley & Sons, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Selection bias and covariate imbalances in randomzied clinical trials [[electronic resource] /] / Vance W. Berger
| Selection bias and covariate imbalances in randomzied clinical trials [[electronic resource] /] / Vance W. Berger |
| Autore | Berger Vance |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley & Sons, c2005 |
| Descrizione fisica | 1 online resource (220 p.) |
| Disciplina |
610.724
610/.72/4 |
| Collana | Statistics in practice |
| Soggetto topico |
Clinical trials - Statistical methods - Evaluation
Ranking and selection (Statistics) - Evaluation Sampling (Statistics) - Evaluation |
| ISBN |
1-280-55597-1
9786610555970 0-470-86364-1 0-470-86363-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Selection Bias and Covariate Imbalances in Randomized Clinical Trials; Contents; Preface; Part I: Is There a Problem with Reliability in Medical Studies?; 1 An Evolution of Comparative Methodology; 1.1 Single-subject studies; 1.2 Case series and cohort studies; 1.3 Historical controls; 1.4 Parallel control groups; 1.5 Matched studies; 1.6 Randomization; 1.7 Advance randomization; 1.8 Allocation concealment; 1.9 Residual selection bias; 2 Susceptibility of Randomized Trials to Subversion and Selection Bias; 2.1 Can randomized trials be subverted?
2.2 If randomized trials are subverted, do they cease to be randomized trials?2.3 What is masking?; 2.4 What is allocation concealment?; 2.5 A double standard; 2.6 What if allocation concealment could be ensured?; 3 Evidence of Selection Bias in Randomized Trials; 3.1 The burden of proof regarding the existence of selection bias in randomized trials; 3.2 Indirect population-level evidence that selection bias exists in randomized trials; 3.3 Direct trial-level evidence that selection bias exists in randomized trials; 3.3.1 Heparin for myocardial infarction 3.3.2 University Group Diabetes Program3.3.3 Talc and mustine for pleural effusions; 3.3.4 Tonsillectomy for recurrent throat infection in children; 3.3.5 Oxytocin and amniotomy for induction of labor; 3.3.6 Western Washington Intracoronary Streptokinase Trial; 3.3.7 RSV immune globulin in infants and young children with respiratory syncytial virus; 3.3.8 A trial to assess episiotomy; 3.3.9 Canadian National Breast Cancer Screening Study; 3.3.10 Surgical trial; 3.3.11 Lifestyle Heart Trial; 3.3.12 Coronary Artery Surgery Study; 3.3.13 Etanercept for children with juvenile rheumatoid arthritis 3.3.14 Edinburgh Randomized Trial of Breast-Cancer Screening3.3.15 Captopril Prevention Project; 3.3.16 Göteborg (Swedish) Mammography Trial; 3.3.17 HIP Mammography Trial; 3.3.18 Hypertension Detection and Follow-Up Program; 3.3.19 Randomized trial to prevent vertical transmission of HIV-1; 3.3.20 Effectiveness trial of a diagnostic test; 3.3.21 South African trial of high-dose chemotherapy for metastatic breast cancer; 3.3.22 Randomized study of a culturally sensitive AIDS education program; 3.3.23 Runaway Youth Study; 3.3.24 Cluster randomized trial of palliative care 3.3.25 Randomized trial of methadone with or without heroin3.3.26 Randomized NINDS trial of tissue plasminogen activator for acute ischemic stroke; 3.3.27 Norwegian Timolol Trial; 3.3.28 Laparoscopic versus open appendectomy; 3.3.29 The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study; 3.3.30 The Heart Outcomes Prevention Evaluation (HOPE) Study; 3.4 In search of better evidence; 4 Impact of Selection Bias in Randomized Trials; 4.1 Quantifying the prediction of future allocations: balanced blocks; 4.2 Quantifying prediction of future allocations: unbalanced blocks 4.3 Quantifying covariate imbalance resulting from selection bias |
| Record Nr. | UNINA-9910830363103321 |
|
Berger Vance
|
||
| Hoboken, NJ, : John Wiley & Sons, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Selection bias and covariate imbalances in randomzied clinical trials / / Vance W. Berger
| Selection bias and covariate imbalances in randomzied clinical trials / / Vance W. Berger |
| Autore | Berger Vance |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley & Sons, c2005 |
| Descrizione fisica | 1 online resource (220 p.) |
| Disciplina | 610/.72/4 |
| Collana | Statistics in practice |
| Soggetto topico |
Clinical trials - Statistical methods - Evaluation
Ranking and selection (Statistics) - Evaluation Sampling (Statistics) - Evaluation |
| ISBN |
1-280-55597-1
9786610555970 0-470-86364-1 0-470-86363-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Selection Bias and Covariate Imbalances in Randomized Clinical Trials; Contents; Preface; Part I: Is There a Problem with Reliability in Medical Studies?; 1 An Evolution of Comparative Methodology; 1.1 Single-subject studies; 1.2 Case series and cohort studies; 1.3 Historical controls; 1.4 Parallel control groups; 1.5 Matched studies; 1.6 Randomization; 1.7 Advance randomization; 1.8 Allocation concealment; 1.9 Residual selection bias; 2 Susceptibility of Randomized Trials to Subversion and Selection Bias; 2.1 Can randomized trials be subverted?
2.2 If randomized trials are subverted, do they cease to be randomized trials?2.3 What is masking?; 2.4 What is allocation concealment?; 2.5 A double standard; 2.6 What if allocation concealment could be ensured?; 3 Evidence of Selection Bias in Randomized Trials; 3.1 The burden of proof regarding the existence of selection bias in randomized trials; 3.2 Indirect population-level evidence that selection bias exists in randomized trials; 3.3 Direct trial-level evidence that selection bias exists in randomized trials; 3.3.1 Heparin for myocardial infarction 3.3.2 University Group Diabetes Program3.3.3 Talc and mustine for pleural effusions; 3.3.4 Tonsillectomy for recurrent throat infection in children; 3.3.5 Oxytocin and amniotomy for induction of labor; 3.3.6 Western Washington Intracoronary Streptokinase Trial; 3.3.7 RSV immune globulin in infants and young children with respiratory syncytial virus; 3.3.8 A trial to assess episiotomy; 3.3.9 Canadian National Breast Cancer Screening Study; 3.3.10 Surgical trial; 3.3.11 Lifestyle Heart Trial; 3.3.12 Coronary Artery Surgery Study; 3.3.13 Etanercept for children with juvenile rheumatoid arthritis 3.3.14 Edinburgh Randomized Trial of Breast-Cancer Screening3.3.15 Captopril Prevention Project; 3.3.16 Göteborg (Swedish) Mammography Trial; 3.3.17 HIP Mammography Trial; 3.3.18 Hypertension Detection and Follow-Up Program; 3.3.19 Randomized trial to prevent vertical transmission of HIV-1; 3.3.20 Effectiveness trial of a diagnostic test; 3.3.21 South African trial of high-dose chemotherapy for metastatic breast cancer; 3.3.22 Randomized study of a culturally sensitive AIDS education program; 3.3.23 Runaway Youth Study; 3.3.24 Cluster randomized trial of palliative care 3.3.25 Randomized trial of methadone with or without heroin3.3.26 Randomized NINDS trial of tissue plasminogen activator for acute ischemic stroke; 3.3.27 Norwegian Timolol Trial; 3.3.28 Laparoscopic versus open appendectomy; 3.3.29 The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study; 3.3.30 The Heart Outcomes Prevention Evaluation (HOPE) Study; 3.4 In search of better evidence; 4 Impact of Selection Bias in Randomized Trials; 4.1 Quantifying the prediction of future allocations: balanced blocks; 4.2 Quantifying prediction of future allocations: unbalanced blocks 4.3 Quantifying covariate imbalance resulting from selection bias |
| Record Nr. | UNINA-9910877200603321 |
|
Berger Vance
|
||
| Hoboken, NJ, : John Wiley & Sons, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||